ClinQua Inc. : The overall cost of clinical trials depends on an array of factors

In a progressive global market of supply and demand, it remains unthinkable to engage in practices that are ambitiously over-priced when there are endless opportunities to utilize more cost-efficient methods which would yield the same results. As per Mr. David Mills former ClinQua Clinical Trials Inc. www.clinqua.com executive the overall cost of clinical trials depends on an array of factors: study design, sample size, number of clinical sites, equipment used, number of visits, number of lab tests. Depending on the service provider you seek to employ to carry out these processes, the asking price could differ by a factor of three. Hence the overall price of a clinical trial can vary considerably. As such, sponsors need to employ companies that have the capacity to monitor and address the various aspects of a trial to ensure that finances do not get out of control for the sake of a clinical investigator's ambitions. Nevertheless, clinical trials are still employed in this manner, with blatant disregard to the financial pitfalls of dogmatic protocols and ideologies of clinical scientists. This is what Clinqua, a CRO (contract research organization), seeks to remedy. They offer a comprehensive approach to clinical design and consultation with principle investigators to prevent difficulties in the early stages of clinical development. Namely, patient recruitment practices, which if mismanaged could lead to inadequate compliance or even worse, excessive patients spread across various trial sites escalating the costs of the trial.